You have access
Hypertension as a Predictive Marker for Bevacizumab in Metastatic Breast Cancer: Results from a Retrospective Matched-pair Analysis
SIMON PETER GAMPENRIEDER, FRANZ ROMEDER, CLAUDIA MUß, MAGDALENA PIRCHER, SIGRUN RESSLER, GABRIEL RINNERTHALER, RUPERT BARTSCH, CLAUDIA SATTLBERGER, BRIGITTE MLINERITSCH and RICHARD GREIL
Anticancer Research January 2014, 34 (1) 227-233;